Market Analysis:
Olanzapine is used for treating specific mood/mental conditions
especially bipolar disorder and schizophrenia. Besides it can be used with
other medications for treating depression. Olanzapine can also help in
decreasing hallucinations thereby helping one in thinking more positively and
clearly about themselves along with feeling less agitated and being more active
in life. This medication is generic and is available in different trade names. Olanzapine
has a couple of minor and major side effects such as loss of libido, cough,
running nose, dry mouth, chest pain, uncontrolled muscle movements, dizziness,
increase in cholesterol and body fat, sleepiness, headache, weight gain and
orthostatic hypotension.
Get a
Free Sample @ https://www.marketresearchfuture.com/sample_request/718
The global Olanzapine market is likely to
grow at an exponential growth rate during the forecast period 2017-2023 and the
driving factors here include rising prevalence of different neurological
disorders such as bipolar disorder, schizophrenia, increasing number of people
with emotional instability and mental illness have further increased the demand
of this medication as a key measure to treat such diseases. Data released by
the National Institute of Health and Care Excellence revealed that olanzapine
is also suggested as the first line therapy for treating acute mania in case of
bipolar disorder. Along with these influencing factors there are some factors
which impact the growth of the Olanzapine market negatively like the
medication’s side effects and different regulatory needs for marketing this
medication that may take a toll on the growth of this market. The Olanzapine
market is forecasted to touch a striking CAGR during the forecast period
2017-2023.
Competitive Analysis:
With the presence of both key and small players, the global Olanzapine Market appears to be extremely competitive and fragmented. In fact, with a
flourishing market in North America and some of the major companies having
their home it is generating maximum share in the market. These companies
expanded their operating unit in many more emerging regions too. Moreover, some
medium and small-scale players are generating good revenue from the local
market. The popular American pharmaceutical, Eli Lilly is a top manufacturer
for the Olanzapine market. There is a growing demand for generic Zyprexa in the
US, the schizophrenia, bipolar treatment from Eli Lilly which has been amid the
highest sellers before turning off patent in the last few years.
Key Players:
Teva Pharmaceutical, Apotex Inc, Mylan
Pharmaceuticals, Dr Reddy’s Laboratories, Lilly, Sun Pharmaceuticals, Torrent
Pharmaceuticals, Jubilant Lifesciencest, Aurobindo Pharma, Hansoh
Pharmaceutical, Zhejiang Langhua Pharmaceuticals, Sandoz, Hanson
Pharmaceutical, and WATSON Pharmaceuticals.
Market Segmentation:
·
In MRFR’s report the global
Olanzapine market is segmented on the basis of types and application.
·
Based on type, the Olanzapine
market is segmented into ZYPREXA ZYDIS, ZYPREXA tablets and ZYPREXA Intra
Muscular (available for injections).
·
Based on applications, this
market is segmented into bipolar disorder, schizophrenia and others.
Regional Analysis:
The global Olanzapine market is segmented into different regions - Americas,
Europe, Asia Pacific and the Middle East and Africa. The Americas leads the
global Olanzapine market, having a market share of more than 40%. What led to
such an impressive market growth here include leading manufacturers creating
the medication in the region and extensive use of this medication by people in
the region. Moreover, different types of neurological disorders mostly
schizophrenia and bipolar disorder constantly on the rise amid individuals have
also led to the growth of the Olanzapine market in the North America Region.
Access Full Report Details @ https://www.marketresearchfuture.com/reports/olanzapine-market-718
Moreover, the market in Europe is
growing gradually and also catching up with the market in America in the near
future. This medication was first launched in Europe on account of a good number
of people being diagnosed with neurological disorders and mental illness.
The Olanzapine market in Asia Pacific
is anticipated to grow at the fastest rate during the forecast period. China
and India in particular are likely to be the fastest growing market. The Middle
East and Africa has the least share and the factors attributed here include
poor medical facilities, lack of awareness and less market access.
Related Reports:
Dental Sleep
Medicine Market Research Report – Global Forecast to 2023
https://www.marketresearchfuture.com/infographics/dental-sleep-medicine-market
Embolization
Particle Market Research Report - Global Forecast till 2023
https://www.marketresearchfuture.com/infographics/embolization-particle-market
No comments:
Post a Comment